4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Synflorix: new trials by email Literature Review of Synflorix trials Research Report on Synflorix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of PCV Schedules in a Naive Population in Vietnam PCV 2p+1, PCV 3p+0, PCV 1p+1 - Pneumonia, Pneumococcal | Phase 4 | Completed | Nagasaki University | 18652 | 2016-10-01 | 2024-04-19 |
| PCV10 Immunogenicity Study Nepal 2015 10-valent pneumococcal conjugate vaccine - Streptococcus Pneumoniae | Phase 4 | Completed | University of Oxford | 304 | 2015-08-21 | 2018-01-11 |
| Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Prevenar13, Synflorix - Otitis Media, Febrile Illness | Phase 4 | Completed | Menzies School of Health Research | 261 | 2013-03-12 | 2020-03-25 |
| Pneumococcal Vaccines Early and in Combination Synflorix, Prevenar13, COMBO - Otitis Media | Phase 4 | Completed | Menzies School of Health Research | 425 | 2011-08-01 | 2018-10-18 |
Otitis Media (2) · Cough (1) · Pneumonia, Pneumococcal (1) · Respiratory Tract Infections (1)
Menzies School of Health Research (2) · Nagasaki University (1) · University of Oxford (1)
Australia (2) · United Kingdom (1) · Vietnam (1)
PMID 35772449, PMID 38829821, PMID 14998500, PMID 20686433, PMID 24086113, PMID 25596202, PMID 30635252, PMID 32448790, PMID 33685411, PMID 37780234, PMID 39602629, PMID 42202846